Stocksigma LogoStocksigma Logo

Sudarshan Pharma Board Approves ₹72 Crore Convertible Warrants Issue to Promoters

Sudarshan Pharma Industries' Board approved raising up to ₹72 crore via the preferential issue and allotment of convertible warrants to promoters Mr

Sudarshan Pharma Board Approves ₹72 Crore Convertible Warrants Issue to Promoters

Sudarshan Pharma Industries Ltd · Others (Uncategorized) · 31 Oct 2026, 1:58 am

Sudarshan Pharma Board Approves ₹72 Crore Convertible Warrants Issue to Promoters Sudarshan Pharma Industries' Board approved raising up to ₹72 crore via the preferential issue and allotment of convertible warrants to promoters Mr. Hemal Mehta and Mr. Sachin Mehta on 29th Oct'26. Each warrant is convertible into one equity share of face value Re 1. The issue price will be determined under Regulation 164 of SEBI ICDR Regulations. The fundraise remains subject to regulatory and shareholder approvals at an upcoming Extraordinary General Meeting.

Original exchange filing (PDF)

More announcements from Sudarshan Pharma Industries Ltd

All Sudarshan Pharma Industries Ltd announcements